Münire BABAYİĞİT, Erbil TÜRKSAL, Mustafa Alparslan BABAYİĞİT, Pınar FIRAT, Gökhan YILDIZ, Adem SELVİ, Aylin KILINÇARSLAN

Yoğun Bakımdaki COVID-19 Hastalarında Kan Transfüzyonu ve İlişkili Faktörlerin Analizi: Tek Merkez Örneği

Amaç: Bu çalışmada COVID-19 Yoğun Bakım Ünitesi’nde (YBÜ) takip edilen hastalarda kan transfüzyonu karakteristiklerini, ilişkili faktörleri ve sonuçlarını tespit etmeyi amaçladık. Gereç ve Yöntemler: COVID-19 tanısıyla 21 Mart 2020 ve 01 Haziran 2020 tarihleri arasında COVID-19 YBÜ’nde takip edilen, 48 saatten uzun süre YBÜ’de kalan hastaların dosyaları retrospektif olarak incelendi. Hastaların demografik verileri, laboratuvar verileri (hemogram, koagülasyon parametreleri, inflamatuvar markerlar, arteriyel kan gazı parametreleri), kalp hızı, arteriyel kan basıncı, kanama bulguları, yaygın intravasküler koagülasyon (DIC) gelişimi, vazopressor ihtiyacı ve kan transfüzyonu ihtiyacı kaydedildi. Bulgular: Kan transfüzyonu uygulanan hastaların yoğun bakımda kalış süreleri [27 (4-65) gün], uy- gulanmayanlara göre [5 (0-30) gün] anlamlı şekilde yüksekti (p0.05). Kronik obstrüktif ak- ciğer hastalığı (KOAH) oranlarının kan transfüzyonu uygulananlarda anlamlı şekilde yüksek olduğu (%33,3 vs %0,0) tespit edildi (p=0.026). Kan transfüzyonu uygulanan grupta fatalite hızı %44,4, trans- füzyon uygulanmayan grupta fatalite hızı %21,1 saptandı (p=0.371). Sonuç: Çalışmamız sonucunda COVID-19 YBÜ’de KOAH tanısı olan, ağır kliniğe sahip olup entübasyon, mekanik ventilasyon gereken, uzun süre yoğun bakımda yatan hastalarda daha çok anemi geliştiği ve kan transfüzyonu yapıldığı, transfüzyon yapılan hastalarda ise mortalitenin yüksek olduğu tespit edilmiştir.

Analysis of Blood Transfusion and Related Factors in COVID-19 Critical Care Patients: Single Center Example

Aim: In this study, we aimed to determine the blood transfusion characteristics, related factors and results in patients followed in the COVID-19 Intensive Care Unit(ICU). Material and Methods: The files of patients who were followed up in the COVID-19 ICU between March 21, 2020 and June 01, 2020 with the diagnosis of COVID-19 and stayed in the ICU for more than 48 hours were retrospectively reviewed. Demographic data of the patients, laboratory data (hemogram, coagulation parameters, inflammatory markers, arterial blood gas parameters), heart rate, arterial blood pressure, bleeding findings, development of disseminated intravascular coagulation (DIC), vasopressor requirement and blood transfusion need were recorded. Results: The length of stay in the intensive care unit [27 (4-65) days] of the patients who received blood transfusion was significantly higher than those who did not [5 (0-30) days] (p 0.05). Chronic obstructive pulmonary disease (COPD) rates were significantly higher in those who received blood transfusion (33.3% vs 0.0%) (p=0.026). The fatality rate was 44.4% in the blood transfused group, and 21.1% in the non-transfused group (p=0.371). Conclusion: As a result of our study, it was determined that patients with a diagnosis of COPD in the COVID-19 ICU, who had a severe clinic and intubation need, mechanical ventilation, and who were hospitalized in the intensive care unit for a long time developed more anemia and blood transfusion, and mortality was higher in patients who underwent transfusion.

PDF

___

1. Ayoğlu H . COVID-19 Hastalarında Yoğun Bakım Yaklaşımı. Türkiye Diyabet ve Obezite Dergisi 2020; 4(2): 183-193.
2. Keddissi JI, Youness HA, Jones KR, Kinasewitz GT. Fluid management in Acute Respiratory Distress Syndrome: A narrative review. Can J Respir Ther 2019;55:1-8.
3. Cinel I, Kasapoglu US, Gul F, Dellinger RP. The initial resuscitation of septic shock. J Crit Care 2020;57:108-117.
4. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020 May;46(5):854-887.
6. Byrne L, Haren FV. Fluid resuscitation in human sepsis: Time to rewrite history? Ann Intensive Care 2017;7:4.
7. The ProCESS Investigators. A Randomized Trial of Protocol- Based Care for Early Septic Shock.N Engl J Med 2014; 370:1683-1693.
8. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettilä V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Müller RG, Møller MH, Steensen M, Tjäder I, Kilsand K, Odeberg-Wernerman S, Sjøbø B, Bundgaard H, Thyø MA, Lodahl D, Mærkedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A; TRISS Trial Group; Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371(15):1381- 1391.
9. The ARISE Investigators and the ANZICS Clinical Trials Grou. Goal-Directed Resuscitation for Patients with Early Septic Shock. N Engl J Med 2014;371:1496-1506.
10. Rhodes A, Evans LE, Alhazzani W. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Critical Care Medicine 2017;45(3):486-552.
11. Corwin HL, Krantz SB. Anemia of the critically ill: Acute anemia of chronic disease. Crit Care Med 2000;28:3098-3099.
12. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 2002;288(12):1499-1507.
13. Groeger JS, Guntupalli KK, Strosberg M, Halpern N, Raphaely RC, Cerra F, Kaye W. Descriptive analysis of critical care units in the United States: Patient characteristics and intensive care unit utilization. Crit Care Med 1993;21(2):279-291.
14. Smoller BR, Kruskall MS. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med 1986;314(19):1233-1235.
15. von Ahsen N, Müller C, Serke S, Frei U, Eckardt KU. Important role of non-diagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999;27:2630-2639.
16. Lelubre C, Piagnerelli M, Vincent JL. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: Myth or reality? Transfusion 2009; 49:1384-1394.
17. Grimshaw K, Sahler J, Spinelli SL, Phipps RP, Blumberg N. New frontiers in transfusion biology: Identification and significance of mediator of morbidity and mortality in stored red blood cells. Transfusion 2011;51:874-880.
18. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: Proven beyond a reasonable doubt. Transfusion 2005;45:33S-39S.
19. Tinmouth A, Fergusson D, Yee IC, Hébert PC; ABLE Investigators; Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion 2006;46:2014-2027.
20. Watkins TC, Clark CT. Critically ill and septic patient: Is red blood cell transfusion adding to the Domino Effect? J Infus Nurs 2013;36(2):116-121.
21. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, Allard S, Thomas D, Walsh T; British Committee for Standards in Haematology. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol 2013;160:445-464.